Top

Supportive Care in Cancer

Published in:

01-03-2013 | Original Article

The association between psychosocial and medical factors with long-term sexual dysfunction after treatment for colorectal cancer

Authors: Kathrin Milbury, Lorenzo Cohen, Rosell Jenkins, John M. Skibber, Leslie R. Schover

Published in: Supportive Care in Cancer | Issue 3/2013

Abstract

Purpose

Colorectal cancer patients usually receive treatments (e.g., pelvic surgery or radiotherapy, colostomy) that increase their risk for sexual problems. Previous research has mainly focused on demographic and medical risk factors. Because little is known about the role of psychosocial variables in sexual dysfunction, this research sought to identify the contribution of demographic, medical, and psychosocial factors to sexual dysfunction using multivariate analyses.

Methods

Male and female colorectal cancer survivors (N = 261; mean, 2.5 years post-treatment) completed paper–pencil questionnaires assessing sexual function, psychosocial variables (e.g., depression, social support, body image, and dyadic adjustment), and demographics. Medical information was obtained from patients' self-report and medical records.

Results

Multiple regression analyses revealed that older age, having received destructive surgery (i.e., abdominoperineal resection), and poor social support were uniquely and significantly associated with low international index of erectile function scores in men. For women, low female sexual function index scores were significantly associated with older age and poor global quality of life. Men, but not women, with rectal cancer reported worse sexual function compared to those with colon cancer.

Conclusions

Sexual dysfunction after colorectal cancer treatment is related to demographic, medical, and psychosocial factors. These associations can help to identify patients at high risk of sexual problems in order to assist restoring sexual functioning if desired.

American Cancer Society (2011) Cancer facts & figures 2011. American Cancer Society, Atlanta

Centers for Disease Control and Prevention (2007) Cancer survivors—United States. MMWR 60:269–272

Jansen L et al (2010) Quality of life among long-term (>/=5 years) colorectal cancer survivors—systematic review. Eur J Cancer 46(16):2879–2888PubMedCrossRef

Hendren SK et al (2005) Prevalence of male and female sexual dysfunction is high following surgery for rectal cancer. Ann Surg 242(2):212–223PubMedCrossRef

Denlinger CS, Barsevick AM (2009) The challenges of colorectal cancer survivorship. J Natl Compr Canc Netw 7(8):883–893, quiz 894PubMed

Ho VP et al (2011) Sexual function after treatment for rectal cancer: a review. Dis Colon Rectum 54(1):113–125PubMedCrossRef

Arndt V et al (2006) Restrictions in quality of life in colorectal cancer patients over 3 years after diagnosis: a population based study. Eur J Cancer 42(12):1848–1857PubMedCrossRef

Camilleri-Brennan J, Steele RJ (2001) Prospective analysis of quality of life and survival following mesorectal excision for rectal cancer. Br J Surg 88(12):1617–1622PubMedCrossRef

Allal AS et al (2005) Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int J Radiat Oncol Biol Phys 61(4):1129–1135PubMedCrossRef

10.

Marijnen CA et al (2005) Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23(9):1847–1858PubMedCrossRef

11.

Vironen JH et al (2006) Impact of functional results on quality of life after rectal cancer surgery. Dis Colon Rectum 49(5):568–578PubMedCrossRef

12.

Maurer CA et al (2001) Total mesorectal excision preserves male genital function compared with conventional rectal cancer surgery. Br J Surg 88(11):1501–1505PubMedCrossRef

13.

Ameda K et al (2005) The long-term voiding function and sexual function after pelvic nerve-sparing radical surgery for rectal cancer. Int J Urol 12(3):256–263PubMedCrossRef

14.

Bonnel C et al (2002) Effects of preoperative radiotherapy for primary resectable rectal adenocarcinoma on male sexual and urinary function. Dis Colon Rectum 45(7):934–939PubMedCrossRef

15.

Schmidt CE et al (2005) Ten-year historic cohort of quality of life and sexuality in patients with rectal cancer. Dis Colon Rectum 48(3):483–492PubMedCrossRef

16.

Guren MG et al (2005) Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol 31(7):735–742PubMedCrossRef

17.

Engel J et al (2003) Quality of life in rectal cancer patients: a four-year prospective study. Ann Surg 238(2):203–213PubMed

18.

Pachler J, Wille-Jorgensen P (2004) Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev 3:CD004323PubMed

19.

Heriot AG et al (2005) Adjuvant radiotherapy is associated with increased sexual dysfunction in male patients undergoing resection for rectal cancer: a predictive model. Ann Surg 242(4):502–510, discussion 510–511PubMed

20.

Thong M et al (2011) Impact of preoperative radiotherapy on general and disease-specific health status of rectal cancer survivors: a population study. Int J Radiat Oncol Biol Phys 81(3):e49–58PubMedCrossRef

21.

Sadovsky R et al (2010) Cancer and sexual problems. J Sex Med 7(1 Pt 2):349–373PubMedCrossRef

22.

Jayne DG et al (2005) Bladder and sexual function following resection for rectal cancer in a randomized clinical trial of laparoscopic versus open technique. Br J Surg 92(9):1124–1132PubMedCrossRef

23.

Engel J et al (2003) The process of metastasisation for breast cancer. Eur J Cancer 39(12):1794–1806PubMedCrossRef

24.

Mannaerts GH et al (2001) Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Eur J Surg Oncol 27(3):265–272PubMedCrossRef

25.

Tekkis PP et al (2009) Measuring sexual and urinary outcomes in women after rectal cancer excision. Dis Colon Rectum 52(1):46–54PubMedCrossRef

26.

Schmidt C et al (2010) Sexual impairment and its effects on quality of life in patients with rectal cancer. Dtsch Arztebl Int 107(8):123–130PubMed

27.

Lynch HT, Lynch JF, Attard TA (2009) Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model. CMAJ 181(5):273–280PubMed

28.

Rosen RC, Cappelleri JC, Gendrano N 3rd (2002) The international index of erectile function (IIEF): a state-of-the-science review. Int J Impot Res 14(4):226–244PubMedCrossRef

29.

Badr H, Carmack-Taylor CL (2009) Sexual dysfunction and spousal communication in couples coping with prostate cancer. Psychooncology 18(7):735–746PubMedCrossRef

30.

Wiegel M, Meston C, Rosen R (2005) The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther 31(1):1–20PubMedCrossRef

31.

Sprangers MA, te Velde A, Aaronson NK (1999) The construction and testing of the EORTC Colorectal Cancer-Specific Quality of Life Questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer 35(2):238–247PubMedCrossRef

32.

Radloff L (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1(3):385–401CrossRef

33.

Zabora J et al (2001) A new psychosocial screening instrument for use with cancer patients. Psychosomatics 42(3):241–246PubMedCrossRef

34.

Sherbourne CD, Stewart AL (1991) The MOS social support survey. Soc Sci Med 32(6):705–714PubMedCrossRef

35.

Hunsley J, Best M, Lefebvre M, Vito D (2001) The seven item short form of the dyadic adjustment scale: further evidence for the construct validity. Am J Fam Ther 29:325–335

36.

Cohen J, Cohen P (1983) Applied regression/correlation analysis for the behavioral sciences, 2nd edn. Lawrence Erlbaum Associates, Hillsdale

37.

Lindau ST, Gavrilova N (2010) Sex, health, and years of sexually active life gained due to good health: evidence from two US population based cross sectional surveys of ageing. BMJ 340:c810PubMedCrossRef

38.

Bohm G et al (2008) Anorectal, bladder, and sexual function in females following colorectal surgery for carcinoma. Int J Color Dis 23(9):893–900CrossRef

39.

Meston C, Trapnell P (2005) Development and validation of a five-factor sexual satisfaction and distress scale for women: the Sexual Satisfaction Scale for Women (SSS-W). J Sex Med 2(1):66–81PubMedCrossRef

40.

Canada AL et al (2005) Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer 104(12):2689–2700PubMedCrossRef

41.

Scott JL, Kayser K (2009) A review of couple-based interventions for enhancing women's sexual adjustment and body image after cancer. Cancer J 15(1):48–56PubMedCrossRef

42.

Huyghe E et al (2009) Needs assessment survey to justify establishing a reproductive health clinic at a comprehensive cancer center. J Sex Med 6(1):149–163PubMedCrossRef

43.

Iecovich E, Jacobs JM, Stessman J (2011) Loneliness, social networks, and mortality: 18 years of follow-up. Int J Aging Hum Dev 72(3):243–263PubMedCrossRef

44.

Rendall MS et al (2011) The protective effect of marriage for survival: a review and update. Demography 48(2):481–506PubMedCrossRef

45.

Flynn KE et al (2012) Patient experiences with communication about sex during and after treatment for cancer. Psychooncology 21(6):594–601PubMedCrossRef

46.

Park ER, Norris RL, Bober SL (2009) Sexual health communication during cancer care: barriers and recommendations. Cancer J 15(1):74–77PubMedCrossRef

47.

Schover LR et al (2002) Defining sexual outcomes after treatment for localized prostate carcinoma. Cancer 95(8):1773–1785

48.

Serati M et al (2009) Sexual function after radical hysterectomy for early-stage cervical cancer: is there a difference between laparoscopy and laparotomy? J Sex Med 6(9):2516–2522

49.

Berra M et al (2010) The impairment of sexual function is less distressing for menopausal than for premenopausal women. J Sex Med 7(3):1209–1215

Title: The association between psychosocial and medical factors with long-term sexual dysfunction after treatment for colorectal cancer
Authors: Kathrin Milbury
Lorenzo Cohen
Rosell Jenkins
John M. Skibber
Leslie R. Schover
Publication date: 01-03-2013
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 3/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-012-1582-9

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2013

Comparison of the effects of aromatase inhibitors and tamoxifen on radiation-induced lung toxicity: results of an experimental study

A theory-based decision aid for patients with cancer: results of feasibility and acceptability testing of DecisionKEYS for cancer

Analysis of the risk factors for myelosuppression after concurrent chemoradiotherapy for patients with advanced non-small cell lung cancer

Fast-track rehabilitation program and conventional care after esophagectomy: a retrospective controlled cohort study

Cardiorespiratory and neuromuscular deconditioning in fatigued and non-fatigued breast cancer survivors

Implementation of modified early-goal directed therapy for sepsis in the emergency center of a comprehensive cancer center

Keynote webinar | Spotlight on antibody–drug conjugates in cancer